today's wacc — Diagnostics & Lab Equipmentⓘ

9.40%

+ new wacc

all›Healthcare›Medical Devices›Diagnostics & Lab Equipment

Hangzhou Tigermed Consulting11.81%

Joinn Laboratories(China)Co.,Ltd11.39%

Metropolis Healthcare11.11%

Guardant Health10.83%

OPKO Health10.46%

Dian Diagnostics Group10.40%

Illumina10.34%

Medpace Holdings10.30%

Guangzhou Kingmed Diagnostics Group10.20%

Mettler-Toledo International9.93%

Agilent Technologies9.74%

Castle Biosciences9.65%

WuXi AppTec9.61%

RadNet9.47%

Charles River Laboratories International9.46%

Waters9.41%

Sotera Health9.39%

Lonza Group9.38%

Dr. Lal PathLabs8.91%

Danaher8.43%

Revvity8.37%

IQVIA Holdings8.24%

Thermo Fisher Scientific8.24%

ICON Public8.23%

Qiagen8.14%

Vijaya Diagnostic Centre7.83%

Sonic Healthcare7.39%

Fleury7.36%

Eurofins Scientific7.35%

NeoGenomics7.30%

Quest Diagnostics7.11%

Shanghai Runda Medical Technology7.01%

H.U. Group Holdings6.34%

methodology

WACC is calculated as the weighted average of the cost of equity and the after-tax cost of debt, using median unlevered betas (5-year monthly, adjusted via Blume) relevered with median net-debt capital structures via the Hamada equation.

Cost of equity = risk-free rate + relevered beta × equity risk premium. Cost of debt = (risk-free rate + credit spread) × (1 − tax rate).

Data is updated daily. Read our full methodology on the sources page.